Company Search:
Advanced Search
Sponsored Links
Exelixis, Inc. Company Snapshot
Exelixis, Inc. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Exelixis with three other companies in this sector in the United States: Natera Inc (2016 sales of $217.07 million of which 100% was Commercial Physical Research), K2m Group Holdings Inc ($236.63 million of which 100% was Medical Devices), and Galapagos NV ($167.34 million of which 80% was R&D).

Sales Analysis. Sales increased substantially in 2016: Exelixis reported sales of $191.45 million for the year ending December of 2016. This represents an increase of 415.0% versus 2015, when the company's sales were $37.17 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Exelixis, Inc.
  Stock Performance Chart for Exelixis, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (11/17/2017): 26.38
(Figures in U.S. Dollars)
1 Week 2.1%   13 Weeks -2.9%  
4 Weeks 0.2%   52 Weeks 55.5%  
Exelixis, Inc. Key Data:
  Ticker: EXEL Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 191,454,000
(Year Ending Jan 2017).
Employees: 287
  Currency: U.S. Dollars Market Cap: 7,800,581,195
  Fiscal Yr Ends: December Shares Outstanding: 295,700,576
  Share Type: Common Closely Held Shares: 17,446,190
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.